Allarity Therapeutics, Inc.
General ticker "ALLR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.5M (TTM average)
Allarity Therapeutics, Inc. follows the US Stock Market performance with the rate: 37.6%.
Estimated limits based on current volatility of 5.5%: low 1.12$, high 1.25$
Factors to consider:
- Total employees count: 9 (-30.8%) as of 2022
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Supply chain disruptions, Clinical development risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.78$, 4.27$]
- 2025-12-31 to 2026-12-31 estimated range: [0.65$, 3.33$]
Short-term ALLR quotes
Long-term ALLR plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $18.34MM |
| Operating Income | $-18.34MM |
| Non-Operating Income | $-7.36MM |
| Interest Expense | $0.65MM |
| R&D Expense | $6.90MM |
| Income(Loss) | $-25.70MM |
| Taxes | $-1.18MM |
| Profit(Loss)* | $-24.52MM |
| Stockholders Equity | $11.81MM |
| Assets | $22.65MM |
| Operating Cash Flow | $-17.35MM |
| Capital expenditure | $0.30MM |
| Investing Cash Flow | $-0.30MM |
| Financing Cash Flow | $36.79MM |
| Earnings Per Share** | $-15.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.